1. $Camtek(CAMT)$ CAMT - Camtek Ltd - midcap company performance since short breakout: -5.47%.2. $BBVA Banco Frances SA(BBAR)$ BBAR - BBVA Banco Frances SA ADR - midcap company performance since short breakout: -3.83%.3. $Snowflake(SNOW)$ SNOW - Snowflake - largecap company performance since short breakout: -2.94%.4. $Dynavax(DVAX)$ DVAX - Dynavax Technologies Corporation - smalecap company performance since long breakout: 4.68%.5. $Mineralys Therapeutics, Inc.(MLYS)$ MLYS - Mineralys Therapeutics Common Stock - smalecap company performance since long breakout: 5.42%.
Top Calls on Wall Street: Apple, Amazon, Netflix, Walmart, Costco and More
Here are Tuesday’s biggest calls on Wall Street:Northcoast upgrades Costco to buy from holdNorthcoast said it sees more upside for the wholesale retailer.“Costco’s performance for its 2QF23 (ended February 12) of $3.30 per share exceeded expectations and set the stage for a strong second semester of fiscal 2023 despite the challenges of high inflation and the reluctance of many consumers to purchase discretionary merchandise.”Goldman Sachs initiates Arista Networks and Juniper as buyGoldman initiated several networking equipment stocks, noting they are attractively valued.“We initiate coverage of America’s Communications Technology stocks includingArista Networks(ANET, Buy), Juniper Networks(JNPR, Buy), Cisco Systems (CSCO, Neutral), and F5 Networks (FFIV, Neutral).”UBS reiterate
A bunch of companies plan to go public this year, companies are rejoining the lineup. In fact, last week was the busiest week for IPOs since October. It was highlighted by solar energy firmNextracker, which became the biggest public offering in four months yesterday. It raised $638 million and sold about 15% more shares than anticipated.IPO Market Warms Up With Busiest US Trading Week Since OctoberChinese companies, which had pulled back from listing in the US last year due to geopolitical tensions, are also plotting their return. Several of them listed on the Nasdaq last week.1-IPOs on Last Week:Lidar-maker $Hesai Group(HSAI)$ （+11% on IPO trading day）Lax preparation service
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.